Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Intensive Care Unit, West China Hospital, Sichuan University, Chengdu, China.
Thorac Cancer. 2021 Dec;12(23):3277-3280. doi: 10.1111/1759-7714.14172. Epub 2021 Oct 20.
The occurrence of ureteral metastasis from distant primary tumors is uncommon, and appears to be especially rare when it originates from the lungs. In the case presented here, a patient with lumbago and left hydronephrosis was diagnosed with left ureteral metastasis of pulmonary adenocarcinoma after a CT-guided percutaneous transthoracic needle biopsy of the lung and retroperitoneal laparoscopic left nephroureterectomy. He accepted the targeted therapy because the lung tumor epidermal growth factor receptor mutation (exon19 deletion) was positive, and preoperative staging of lung adenocarcinoma was stage IVA. After an 8-month follow-up, he is still alive and well, with no local recurrence or distant metastases. The therapy outcome assessment is stable disease. Although rare, our case has demonstrated that pulmonary adenocarcinoma has the possibility of metastasizing to the ureter, a risk that should be considered in some lung cancer patients.
输尿管转移来自远处原发肿瘤的情况并不常见,当起源于肺部时似乎更为罕见。在本例中,一名腰痛和左侧肾积水的患者在接受 CT 引导下经皮经胸肺穿刺活检和腹膜后腹腔镜左肾输尿管切除术,被诊断为左侧输尿管肺腺癌转移。由于肺肿瘤表皮生长因子受体突变(外显子 19 缺失)阳性,他接受了靶向治疗,术前肺腺癌分期为 IVA 期。经过 8 个月的随访,他仍然存活且状况良好,无局部复发或远处转移。治疗效果评估为疾病稳定。尽管罕见,但我们的病例表明,肺腺癌有可能转移至输尿管,这一风险在某些肺癌患者中应予以考虑。